Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 5,843 | 5,616 | 7,262 | 4,362 | 4,877 |
| Cost of Goods | 5,456 | 5,405 | 8,452 | 4,894 | 5,280 |
| Gross Profit | 387 | 211 | -1,190 | -532 | -403 |
| Operating Expenses | 3,720 | 4,383 | 6,856 | 8,537 | 7,101 |
| Operating Income | -3,333 | -4,172 | -8,046 | -9,069 | -7,504 |
| Interest Expense | 5 | 10 | 16 | 3 | 2 |
| Other Income | 250 | -1,433 | 132 | 85 | 49 |
| Pre-tax Income | -3,088 | -5,615 | -7,930 | -8,987 | -7,457 |
| Income Tax | N/A | -6 | 0 | 0 | N/A |
| Net Income Continuous | -3,088 | -5,609 | -7,930 | -8,987 | -7,457 |
| Net Income | $-3,088 | $-5,609 | $-7,930 | $-8,987 | $-7,457 |
| EPS Basic Total Ops | -0.01 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.03 | -0.03 | -0.03 |
| EBITDA(a) | $-2,593 | $-5,065 | $-7,160 | $-8,225 | $-6,636 |